Press release

Wardmore reports portfolio results for the third quarter of 2026

— Wardmore Health Capital today reported portfolio results for the quarter ended September 30, 2026.

  • New fundings of $241.7 million, up 11.4 percent from the third quarter of 2025, across 1,288 assets at 74 hospitals.
  • Assets under management of $2.31 billion at September 30, 2026, including the receivables held by Wardmore Healthcare Equipment Receivables Trusts 2025-1 and 2026-1.
  • Accounts 60 or more days past due at 0.71 percent of the portfolio balance, compared with 0.84 percent a year earlier. Net losses of 0.22 percent, annualized.
  • 3,947 intensive-care beds on Utilization Pricing at quarter end, at an average occupancy of 81.6 percent.

“Fundings were strongest in the Rural Hospital Program and in monitor refreshes, which together made up more than half of the quarter’s volume,” said Anil Raghavan, Chief Financial Officer. “Credit performance remains well inside the levels assumed when both of our trusts were rated.”

Monthly distribution reports for the 2025-1 and 2026-1 trusts are published on the company’s investor pages.

About Wardmore Health Capital

Wardmore Health Capital finances intensive-care beds, ventilators and patient monitoring for more than 600 hospitals in 37 states and three Canadian provinces, and has funded more than $4.8 billion of equipment since 2014. The company is based in Nashville, Tennessee, with an office in Toronto.

Contact

Investors: Hannah Lofgren, Vice President, Investor Relations and Treasury, investors@wardmorehealth.com. Media: Rachel Dunagan, Director of Communications, press@wardmorehealth.com